Draft:Josef H. von Rickenbach

Submission declined on 1 April 2024 by Greenman (talk). This submission is not adequately supported by reliable sources. Reliable sources are required so that information can be verified. If you need help with referencing, please see Referencing for beginners and Citing sources. If you would like to continue working on the submission, click on the "Edit" tab at the top of the window. If you have not resolved the issues listed above, your draft will be declined again and potentially deleted. If you need extra help, please ask us a question at the AfC Help Desk or get live help from experienced editors. Please do not remove reviewer comments or this notice until the submission is accepted. Where to get help If you need help editing or submitting your draft, please ask us a question at the AfC Help Desk or get live help from experienced editors. These venues are only for help with editing and the submission process, not to get reviews. If you need feedback on your draft, or if the review is taking a lot of time, you can try asking for help on the talk page of a relevant WikiProject. Some WikiProjects are more active than others so a speedy reply is not guaranteed. How to improve a draft Wikipedia:Contributing to Wikipedia – a basic overview on how to edit Wikipedia. Help:Wikitext – how to use the markup Help:Referencing for beginners – how to include references Wikipedia:Article development – how to develop your article Wikipedia:Writing better articles – how to improve your article Wikipedia:Verifiability – make sure your article includes reliable third-party sources You can also browse Wikipedia:Featured articles and Wikipedia:Good articles to find examples of Wikipedia's best writing on topics similar to your proposed article. Improving your odds of a speedy review To improve your odds of a faster review, tag your draft with relevant WikiProject tags using the button below. This will let reviewers know a new draft has been submitted in their area of interest. For instance, if you wrote about a female astronomer, you would want to add the Biography, Astronomy, and Women scientists tags. Add tags to your draft Editor resources Find sources: Google (books · news · scholar · free images · WP refs) · FENS · JSTOR · TWL Easy tools: Citation bot (help) | Advanced: Fix bare URLs Declined by Greenman 59 days ago. Last edited by Greenman 59 days ago. Reviewer: Inform author. Resubmit Please note that if the issues are not fixed, the draft will be declined again.

Submission declined on 7 March 2024 by Superboilles (talk). This submission's references do not show that the subject qualifies for a Wikipedia article—that is, they do not show significant coverage (not just passing mentions) about the subject in published, reliable, secondary sources that are independent of the subject (see the guidelines on the notability of people). Before any resubmission, additional references meeting these criteria should be added (see technical help and learn about mistakes to avoid when addressing this issue). If no additional references exist, the subject is not suitable for Wikipedia. Declined by Superboilles 2 months ago.

Submission declined on 26 October 2023 by Tagishsimon (talk). This submission's references do not show that the subject qualifies for a Wikipedia article—that is, they do not show significant coverage (not just passing mentions) about the subject in published, reliable, secondary sources that are independent of the subject (see the guidelines on the notability of people). Before any resubmission, additional references meeting these criteria should be added (see technical help and learn about mistakes to avoid when addressing this issue). If no additional references exist, the subject is not suitable for Wikipedia. Declined by Tagishsimon 7 months ago.

• Comment: See WP:COI and WP:BLP. Statements, starting with the date of birth, need to be sourced or removed. Greenman (talk) 06:20, 1 April 2024 (UTC)

• Comment: The best way to show notability for a given subject is to use citations from publications that are not related to the subject (e.g. earned media, as opposite to paid media). Press releases and coroporate pages don't work in that regard. Superboilles (talk) 18:56, 7 March 2024 (UTC)

• Comment: You need to add citations to reliable sources to demonstrate notability. WP:RS, WP:N, Help:Referencing for beginners Tagishsimon (talk) 20:36, 26 October 2023 (UTC)

Josef H. von Rickenbach (born November 10, 1954) is a Swiss-American businessman. He is the Managing Director of Stet vision LLC.^[1] He is a Senior Advisor at General Atlantic global growth equity^[2] and a director of its portfolio company Javara, Inc.^[3] He serves as Chairman of the Board at ZAGENO Inc.^[4] Previously, Mr. von Rickenbach was co-Founder & CEO of Helio Vision, Inc., an ophthalmic biopharma company.

Early life and education

Born in Switzerland, Mr. von Rickenbach holds a B.A. in Business Economics from Lucerne University in Switzerland, and an MBA from Harvard Business School.

Parexel

Mr. von Rickenbach was co-Founder, Chairman & CEO of PAREXEL International Corporation.^[5] He took PAREXEL from its pioneering beginnings as one of the first clinical research organizations (CROs) in the early 1980s to one of the top global biopharmaceutical services firms. He led PAREXEL through its IPO, multiple private and public offerings, and over 40 mergers and acquisitions. During his 36 years at the helm of the Company, PAREXEL evolved to provide a comprehensive range of drug development services, including globally integrated clinical development, regulatory affairs consulting, commercialization services and clinical trials information technologies. In a $5 billion “going private” transaction in 2017, PAREXEL was acquired by Private Equity, and transacted again for $8.5 billion in 2021 to a new set of PE owners.

Foreseeing the globalization of clinical research, Mr. von Rickenbach worked to expand PAREXEL’s global footprint to 86 locations in 51 countries. This extensive geographical presence and the Company’s 20,000 employees allow PAREXEL to conduct clinical trials across every continent and in more than 100 countries.

Through PAREXEL, Mr. von Rickenbach made several innovative contributions to the advancement of the biopharmaceutical services industry. He conceived of a streamlined, multi-disciplinary, systems-oriented approach to outsourced clinical development bringing efficiencies, speed, scalability and standardization to the process. As part of the industry’s first S-1 filing to the SEC, he was among the first to define the CRO industry in formal terms. As the industry adopted information technology, Mr. von Rickenbach instituted a leading advanced technology offering. Today, the former PAREXEL Informatics operates as Calyx Clinical Trial Solutions, Inc. and is a front runner in providing eClinical Solutions to the global biopharma industry. ^{[6] [7][8] [9]}

Board Memberships

Current

• Zageno, Chairman^[10]
• Aileron Therapeutics, Chairman^[11]
• Javara, Inc. Board Member
• ShapeTX, Board Observer^[12]

Past

• Chairman of the Board, PAREXEL International Corp. Biopharma Services / Clinical Research.
• Board Member, IRIS S.A., Belgium. Now a division of Canon, Inc. Optical Character Recognition Technology.
• Board Member, Epidauros Biotechnologie AG, Germany. Now a division of Danaher Corp. Pharmacogenetic and Genotyping Research.
• Board Member, Tektagen, Inc. Biosafety and Analytical Testing. Now a division of Charles River Laboratories International, Inc.
• Board Member, Next Generation Acquisition Corp. SPAC. Merged with Xos, Inc.
• Board Member, Next Generation Acquisition Corp. II. SPAC. Merged with Virgin Orbit.

Philanthropy and community involvement

Mr. von Rickenbach serves as a board trustee at McLean Hospital, a leading institution in behavioral health.

He also serves as a director at the Network for Excellence in Health Innovation (NEHI), a member-based, non-partisan research and policy organization

He previously served as a board Member for the Biomedical Science Careers Program (BSCP), an inner-city Youth Support for the Pursuit of Biomedical Science Careers.

Awards and recognition

He was named Executive of the Year in North America in the 2010 International Business Awards,^[13] which celebrate managerial excellence worldwide. Mr. von Rickenbach won the Ernst & Young New England Entrepreneur of the Year Award in 1997 and has also served as a judge of the program. In 2013, Mr. von Rickenbach was honored by the Massachusetts Biotechnology Council (MassBio) with the Henri Termeer Innovative Leadership Award. In 2014, he was named Immigrant Entrepreneur of the Year in Life Sciences. In 2018, he received the Scrip Informa Lifetime Achievement Award and was awarded the Ellis Island Medal of Honor.^[14]

References